EU approves Gilead's HIV drug combo

02/24/2005 | iWon

Gilead Sciences reports it received European Commission approval to market its HIV drug Truvada in the European Union. Truvada combines two HIV drugs, Emtriva and Viread, in one pill, which can be taken once a day along with other antiretroviral medicines.

View Full Article in:

iWon

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC